Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07090075Aexternal-prioritypatent/EP1982976A1/en
Application filed by Intendis GmbhfiledCriticalIntendis Gmbh
Publication of NZ615733ApublicationCriticalpatent/NZ615733A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The disclosure relates to a chiral synthetic routes and intermediates for the manufacture of chiral anti-inflammatory agents which are enantiomerically pure form of substituted benzofuran derivatives represented by general formula (VIII) in which at least one of the groups X1, X2, X3 is selected from fluoro, chloro, bromo, hydroxy, methoxy, ethoxy, trifluoromethyl, amino whereas the other groups X1, X2, X3 have the meaning of a hydrogen atom, in which at least one of the groups Z1, Z2, Z3 is selected from -O-, -S-, -NH-, -N(-CH3)-, whereas the other groups Z1, Z2, Z3 have the meaning of a -CH2- group, and in which Ar is an aromatic group, wherein the enantiomeric purity of these compounds is greater than 80%.
NZ61573308A2007-04-182008-04-17Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
NZ615733A
(en)
INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11-ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS